Dean KI, Campus North
Dean KI, Campus North
Anna Martling is Professor of Surgery at Karolinska Institutet and Senior Consultant Colorectal Surgeon at Karolinska University Hospital, Stockholm, Sweden. She defended her thesis on rectal cancer in 2003 and became a board certified surgeon in 2004 and an Associate Professor of Surgery in 2009. Since 2008 she has been research group leader and responsible for the research field of colorectal surgery with special focus on clinical, translational and epidemiological studies on colorectal cancer. A special interest has been radiotherapy, timing of surgery, development of surgical techniques and Aspirin in colorectal cancer treatment. In 2013 Anna Martling was awarded the Swedish Society of Surgery Major Research Prize. Martling is a frequent speaker in national and international scientific meetings.
Since 2013 Anna Martling is the chairman of research at the clinical department. She has several commissions of trust (European Society of Colo Proctology (ESCP), United European Gastroenterology Federation (UEGF), Swedish Cancer Society etc.) and is an assisting Editor of the European Journal of Surgical Oncology, Colorectal Disease and British Journal of Surgery. In 2014 she became Professor of Surgery at the Karolinska Institutet. Since 2015 Martling is chairman for the scientific committee and responsible for the programme of the annual meeting of European Society of Coloproctology. Since 2015 she is member of the board of research at Karolinska Institutet among many other board committments.
Anna Martling's research is funded by the Swedish Research Council, Swedish Cancer Society, Stockholm Cancer Society, the Karolinska Institutet and the Stockholm County Council (ALF). In 2014 she received the Research Council´s largest ever contribution to clinical treatment research at MSEK 25.
Research group leader of the group Colorectal Surgery
Five selected publications:
Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B Lancet 2000 Jul;356(9224):93-6
The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B, Cancer 2001 Aug;92(4):896-902
Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression. Genander M, Halford MM, Xu NJ, Eriksson M, Yu Z, Qiu Z, et al Cell 2009 Nov;139(4):679-92
Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Pettersson D, Cedermark B, Holm T, Radu C, Påhlman L, Glimelius B, et al Br J Surg 2010 Apr;97(4):580-7
Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Erlandsson J, Holm T, Pettersson D, Berglund Å, Cedermark B, Radu C, et al Lancet Oncol. 2017 03;18(3):336-346
Academic honours, awards and prizes
Hilda and Alfred Eriksson's Prize 2018
Swedish Surgical Society Major Research Prize 2013